The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Impact of positive resection margins on recurrence and survival following resection and adjuvant chemotherapy in pancreatic cancer: Results of the PRODIGE 24-CCTG PA-6 trial.
 
Aurélien Lambert
Consulting or Advisory Role - Advanced Accelerator Applications; AstraZeneca/MedImmune; Bayer; GlaxoSmithKline; Ipsen; Janssen; Merck KGaA; Merck Serono; Novartis; Pierre Fabre; Servier/Pfizer
Travel, Accommodations, Expenses - Merck KGaA; Pfizer
 
Julia Salleron
No Relationships to Disclose
 
Alexandre Harle
Honoraria - AstraZeneca; Biocartis; GlaxoSmithKline; MSD Oncology; Pierre Fabre; SOPHiA Genetics
Consulting or Advisory Role - AstraZeneca; GlaxoSmithKline; Janssen Oncology; SOPHiA Genetics
 
James Joseph Biagi
No Relationships to Disclose
 
Agnès Leroux
No Relationships to Disclose
 
Jacques Thomas
No Relationships to Disclose
 
Laure Monard
No Relationships to Disclose
 
Jerome Cros
No Relationships to Disclose
 
Frédéric Marchal
No Relationships to Disclose
 
Ahmet Ayav
No Relationships to Disclose
 
Thierry Conroy
No Relationships to Disclose